Covid-19: AstraZeneca resumes clinical trial of possible coronavirus vaccine following interruption due to adverse events
AstraZeneca has resumed its clinical trial of a potential coronavirus vaccine, following interruption due to adverse events. The trial was paused after a patient developed an ‘unexplained illness.’ There are no details about the patient’s …
